针对结核病的蛋白质子单位疫苗的进展
Ying Zhang1, Jin-Chuan Xu1, Zhi-Dong Hu1,2
1Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Frontiers in immunology
|September 1, 2023
概括
蛋白子单位疫苗在结核病 (TB) 预防和治疗方面表现有前途,为有限的Bacille Calmette-Guérin (BCG) 疫苗提供了替代方案. 生物信息学的进步和辅助剂的开发是他们成功的关键.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
背景情况:
- 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 仍然是一个严重的全球健康威胁,死亡率高.
- 目前的Bacille Calmette-Guérin (BCG) 疫苗在保护成年人免受结核病的影响方面存在局限性.
- 蛋白子单元疫苗代表了对结核病控制的有希望的替代策略.
研究的目的:
- 审查针对结核病的蛋白质子单位疫苗研究的最新进展.
- 突出新型疫苗策略在抗击结核病方面的潜力.
- 促进优化蛋白质亚单元疫苗用于结核病根除.
主要方法:
- 利用生物信息学和结构生物学用于Mtb抗原的识别和优化.
- 通过融合免疫主导抗原来开发多阶段子单元疫苗.
- 使用新型辅助剂来增强疫苗免疫性.
- 使用先进的动物模型进行临床前疫苗有效性评估.
主要成果:
- 蛋白子单位疫苗显示出预防和治疗结核病的潜力.
- 通过结合来自不同感染阶段的抗原,正在开发多阶段子单位疫苗.
- 新的辅助剂正在提高亚单元疫苗的疗效.
- 使用改进的动物模型进行的临床前评估正在产生更准确的保护数据.
结论:
- 蛋白子单位疫苗是一个快速发展的领域,具有克服当前结核病疫苗局限性的巨大潜力.
- 持续的研究和开发,特别是在抗原选择和辅助技术方面,对于成功根除结核病至关重要.
- 各种科学学科的整合正在加速开发有效的结核病蛋白子单元疫苗.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.3K
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.4K
相关概念视频
01:28Pulmonary Tuberculosis V
200
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200
01:26Pulmonary Tuberculosis IV
162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
01:29Pulmonary Tuberculosis I
265
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
265
01:29Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
01:28Pulmonary Tuberculosis II
262
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
262
01:51Vaccinations
44.7K
Overview
44.7K